Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital

BACKGROUND: There is an urgent need to reduce mortality of COVID-19. We examined if corticosteroids and tocilizumab reduce risk for death in patients with severe pneumonia caused by SARS-CoV-2. METHODS: A retrospective cohort study was performed in a single university hospital. All adult patients ad...

Full description

Saved in:
Bibliographic Details
Published in:Infect Dis (Lond)
Main Authors: Van den Eynde, E., Gasch, O., Oliva, J. C., Prieto, E., Calzado, S., Gomila, A., Machado, M. L., Falgueras, L., Ortonobes, S., Morón, A., Capilla, S., Navarro, G., Oristrell, J., Cervantes, M., Navarro, M.
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919103/
https://ncbi.nlm.nih.gov/pubmed/33620019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23744235.2021.1884286
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items